HealthStream (HSTM)
(Delayed Data from NSDQ)
$25.92 USD
0.00 (0.00%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $25.97 +0.05 (0.19%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HSTM 25.92 0.00(0.00%)
Will HSTM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HSTM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HSTM
5 Stocks With Recent Dividend Hike to Watch Amid Volatility
Lyft (LYFT) Tops Q4 Earnings and Revenue Estimates
HSTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zscaler, Inc. (ZS) Hits Fresh High: Is There Still Room to Run?
HealthStream (HSTM) Beats Q3 Earnings Estimates
HealthStream (HSTM) Tops Q2 Earnings and Revenue Estimates
Other News for HSTM
HealthStream (NASDAQ:HSTM): Strong Financial Results in a Fast-Growing Sector
HealthStream Inc (HSTM) Q1 2024 Earnings Call Transcript Highlights: Impressive Growth and ...
Analysts Conflicted on These Healthcare Names: HealthStream (HSTM) and Option Care Health (OPCH)
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), HealthStream (HSTM) and Vertex Pharmaceuticals (VRTX)
Barclays Sticks to Its Buy Rating for HealthStream (HSTM)